ID   TBRG1_HUMAN             Reviewed;         411 AA.
AC   Q3YBR2; Q53GJ5; Q66ZJ6; Q69YS7; Q8TCS4; Q8TEI4; Q96SV0;
DT   06-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   27-SEP-2005, sequence version 1.
DT   28-JUN-2023, entry version 133.
DE   RecName: Full=Transforming growth factor beta regulator 1;
DE   AltName: Full=Nuclear interactor of ARF and Mdm2;
GN   Name=TBRG1; Synonyms=NIAM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION,
RP   TISSUE SPECIFICITY, INTERACTION WITH CDKN2A AND MDM2, AND UBIQUITINATION.
RC   TISSUE=Pancreas;
RX   PubMed=17110379; DOI=10.1074/jbc.m609612200;
RA   Tompkins V.S., Hagen J., Frazier A.A., Lushnikova T., Fitzgerald M.P.,
RA   di Tommaso A.D., Ladeveze V., Domann F.E., Eischen C.M., Quelle D.E.;
RT   "A novel nuclear interactor of ARF and MDM2 (NIAM) that maintains
RT   chromosomal stability.";
RL   J. Biol. Chem. 282:1322-1333(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Zhou G., Li M., Li H., Shen C., Zhong G., Lin L., Yang S.;
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Kidney;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 220-411.
RC   TISSUE=Amygdala, and Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   INTERACTION WITH CDKN2A.
RX   PubMed=16582619;
RA   Tompkins V., Hagen J., Zediak V.P., Quelle D.E.;
RT   "Identification of novel ARF binding proteins by two-hybrid screening.";
RL   Cell Cycle 5:641-646(2006).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-10, CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE
RP   ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 179-324.
RX   PubMed=20506279; DOI=10.1002/pro.404;
RA   Garcia-Alai M.M., Allen M.D., Joerger A.C., Bycroft M.;
RT   "The structure of the FYR domain of transforming growth factor beta
RT   regulator 1.";
RL   Protein Sci. 19:1432-1438(2010).
CC   -!- FUNCTION: Acts as a growth inhibitor. Can activate p53/TP53, causes G1
CC       arrest and collaborates with CDKN2A to restrict proliferation, but does
CC       not require either protein to inhibit DNA synthesis. Redistributes
CC       CDKN2A into the nucleoplasm. Involved in maintaining chromosomal
CC       stability. {ECO:0000269|PubMed:17110379}.
CC   -!- SUBUNIT: Interacts with CDKN2A and MDM2. {ECO:0000269|PubMed:16582619,
CC       ECO:0000269|PubMed:17110379}.
CC   -!- INTERACTION:
CC       Q3YBR2; O14645: DNALI1; NbExp=3; IntAct=EBI-2800552, EBI-395638;
CC       Q3YBR2; O14901: KLF11; NbExp=3; IntAct=EBI-2800552, EBI-948266;
CC       Q3YBR2; D3DTS7: PMP22; NbExp=3; IntAct=EBI-2800552, EBI-25882629;
CC       Q3YBR2; Q8NB12: SMYD1; NbExp=3; IntAct=EBI-2800552, EBI-8463848;
CC       Q3YBR2; Q96E35: ZMYND19; NbExp=3; IntAct=EBI-2800552, EBI-746595;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17110379}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q3YBR2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q3YBR2-2; Sequence=VSP_022645;
CC       Name=3;
CC         IsoId=Q3YBR2-3; Sequence=VSP_022644;
CC   -!- TISSUE SPECIFICITY: Widely expressed at low levels in most tissues,
CC       with highest levels in pancreas, lung and liver. Expression is
CC       decreased in primary tumors including lung, liver, breast, pancreas and
CC       kidney carcinomas, chronic lymphocytic leukemia and diffuse large B-
CC       cell lymphoma. {ECO:0000269|PubMed:17110379}.
CC   -!- PTM: Ubiquitinated; mediated by MDM2 and leading to its subsequent
CC       proteasomal degradation. {ECO:0000269|PubMed:17110379}.
CC   -!- SIMILARITY: Belongs to the TBRG1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB84966.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ144542; AAZ76016.1; -; mRNA.
DR   EMBL; AK027527; BAB55177.1; -; mRNA.
DR   EMBL; AK074140; BAB84966.1; ALT_FRAME; mRNA.
DR   EMBL; AY696294; AAU10523.1; -; mRNA.
DR   EMBL; AK222936; BAD96656.1; -; mRNA.
DR   EMBL; BC109269; AAI09270.1; -; mRNA.
DR   EMBL; AL713631; CAD28450.1; -; mRNA.
DR   EMBL; AL831881; CAH10595.1; -; mRNA.
DR   CCDS; CCDS8448.2; -. [Q3YBR2-1]
DR   RefSeq; NP_116200.2; NM_032811.2. [Q3YBR2-1]
DR   RefSeq; XP_016873931.1; XM_017018442.1. [Q3YBR2-2]
DR   PDB; 2WZO; X-ray; 1.60 A; A=179-324.
DR   PDBsum; 2WZO; -.
DR   AlphaFoldDB; Q3YBR2; -.
DR   SMR; Q3YBR2; -.
DR   BioGRID; 124337; 23.
DR   IntAct; Q3YBR2; 21.
DR   STRING; 9606.ENSP00000409016; -.
DR   GlyGen; Q3YBR2; 3 sites, 1 O-linked glycan (3 sites).
DR   iPTMnet; Q3YBR2; -.
DR   PhosphoSitePlus; Q3YBR2; -.
DR   BioMuta; TBRG1; -.
DR   DMDM; 121943045; -.
DR   EPD; Q3YBR2; -.
DR   jPOST; Q3YBR2; -.
DR   MassIVE; Q3YBR2; -.
DR   MaxQB; Q3YBR2; -.
DR   PaxDb; Q3YBR2; -.
DR   PeptideAtlas; Q3YBR2; -.
DR   ProteomicsDB; 61892; -. [Q3YBR2-1]
DR   ProteomicsDB; 61893; -. [Q3YBR2-2]
DR   ProteomicsDB; 61894; -. [Q3YBR2-3]
DR   Antibodypedia; 45986; 169 antibodies from 25 providers.
DR   DNASU; 84897; -.
DR   Ensembl; ENST00000441174.8; ENSP00000409016.3; ENSG00000154144.13. [Q3YBR2-1]
DR   GeneID; 84897; -.
DR   KEGG; hsa:84897; -.
DR   MANE-Select; ENST00000441174.8; ENSP00000409016.3; NM_032811.3; NP_116200.2.
DR   UCSC; uc001qak.5; human. [Q3YBR2-1]
DR   AGR; HGNC:29551; -.
DR   CTD; 84897; -.
DR   DisGeNET; 84897; -.
DR   GeneCards; TBRG1; -.
DR   HGNC; HGNC:29551; TBRG1.
DR   HPA; ENSG00000154144; Low tissue specificity.
DR   MIM; 610614; gene.
DR   neXtProt; NX_Q3YBR2; -.
DR   OpenTargets; ENSG00000154144; -.
DR   PharmGKB; PA134926528; -.
DR   VEuPathDB; HostDB:ENSG00000154144; -.
DR   eggNOG; KOG4443; Eukaryota.
DR   GeneTree; ENSGT00390000013374; -.
DR   HOGENOM; CLU_037126_0_0_1; -.
DR   InParanoid; Q3YBR2; -.
DR   OMA; RIAYHTE; -.
DR   OrthoDB; 5477148at2759; -.
DR   PhylomeDB; Q3YBR2; -.
DR   TreeFam; TF324736; -.
DR   PathwayCommons; Q3YBR2; -.
DR   SignaLink; Q3YBR2; -.
DR   BioGRID-ORCS; 84897; 12 hits in 1160 CRISPR screens.
DR   ChiTaRS; TBRG1; human.
DR   EvolutionaryTrace; Q3YBR2; -.
DR   GeneWiki; TBRG1; -.
DR   GenomeRNAi; 84897; -.
DR   Pharos; Q3YBR2; Tbio.
DR   PRO; PR:Q3YBR2; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q3YBR2; protein.
DR   Bgee; ENSG00000154144; Expressed in granulocyte and 178 other tissues.
DR   ExpressionAtlas; Q3YBR2; baseline and differential.
DR   Genevisible; Q3YBR2; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HGNC-UCL.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0006260; P:DNA replication; IMP:HGNC-UCL.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IMP:HGNC-UCL.
DR   GO; GO:1990173; P:protein localization to nucleoplasm; IDA:HGNC-UCL.
DR   GO; GO:0050821; P:protein stabilization; IMP:HGNC-UCL.
DR   GO; GO:0051726; P:regulation of cell cycle; IMP:HGNC-UCL.
DR   Gene3D; 3.30.160.360; -; 1.
DR   InterPro; IPR003889; FYrich_C.
DR   InterPro; IPR003888; FYrich_N.
DR   InterPro; IPR040092; TBRG1.
DR   PANTHER; PTHR22715; TRANSFORMING GROWTH FACTOR BETA REGULATED GENE 1; 1.
DR   PANTHER; PTHR22715:SF0; TRANSFORMING GROWTH FACTOR BETA REGULATOR 1; 1.
DR   Pfam; PF05965; FYRC; 1.
DR   Pfam; PF05964; FYRN; 1.
DR   SMART; SM00542; FYRC; 1.
DR   SMART; SM00541; FYRN; 1.
DR   PROSITE; PS51543; FYRC; 1.
DR   PROSITE; PS51542; FYRN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell cycle; Nucleus;
KW   Phosphoprotein; Reference proteome; Tumor suppressor; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   CHAIN           2..411
FT                   /note="Transforming growth factor beta regulator 1"
FT                   /id="PRO_0000274218"
FT   DOMAIN          182..241
FT                   /note="FYR N-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00875"
FT   DOMAIN          242..321
FT                   /note="FYR C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00876"
FT   REGION          1..29
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          119..146
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        131..146
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         10
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..224
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_022644"
FT   VAR_SEQ         1..197
FT                   /note="MSLLDGLASSPRAPLQSSKARMKKLPKKSQNEKYRLKYLRLRKAAKATVFEN
FT                   AAICDEIARLEEKFLKAKEERRYLLKKLLQLQALTEGEVQAAAPSHSSSLPLTYGVASS
FT                   VGTIQGAGPISGPSTGAEEPFGKKTKKEKKEKGKENNKLEVLKKTCKKKKMAGGARKLV
FT                   QPIALDPSGRPVFPIGLGGLTVYSLGE -> MVWPALWELYRELGLFQGPALGLRNHLG
FT                   RKLRRRKKKKAKRTTNWK (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.3,
FT                   ECO:0000303|Ref.4"
FT                   /id="VSP_022645"
FT   CONFLICT        406
FT                   /note="P -> S (in Ref. 4; BAD96656)"
FT                   /evidence="ECO:0000305"
FT   STRAND          185..187
FT                   /evidence="ECO:0007829|PDB:2WZO"
FT   STRAND          190..197
FT                   /evidence="ECO:0007829|PDB:2WZO"
FT   HELIX           203..205
FT                   /evidence="ECO:0007829|PDB:2WZO"
FT   STRAND          214..223
FT                   /evidence="ECO:0007829|PDB:2WZO"
FT   STRAND          230..240
FT                   /evidence="ECO:0007829|PDB:2WZO"
FT   STRAND          242..251
FT                   /evidence="ECO:0007829|PDB:2WZO"
FT   HELIX           255..257
FT                   /evidence="ECO:0007829|PDB:2WZO"
FT   STRAND          259..263
FT                   /evidence="ECO:0007829|PDB:2WZO"
FT   HELIX           264..279
FT                   /evidence="ECO:0007829|PDB:2WZO"
FT   HELIX           290..294
FT                   /evidence="ECO:0007829|PDB:2WZO"
FT   HELIX           299..305
FT                   /evidence="ECO:0007829|PDB:2WZO"
FT   HELIX           311..313
FT                   /evidence="ECO:0007829|PDB:2WZO"
SQ   SEQUENCE   411 AA;  44946 MW;  C6FDE7D7961E78C4 CRC64;
     MSLLDGLASS PRAPLQSSKA RMKKLPKKSQ NEKYRLKYLR LRKAAKATVF ENAAICDEIA
     RLEEKFLKAK EERRYLLKKL LQLQALTEGE VQAAAPSHSS SLPLTYGVAS SVGTIQGAGP
     ISGPSTGAEE PFGKKTKKEK KEKGKENNKL EVLKKTCKKK KMAGGARKLV QPIALDPSGR
     PVFPIGLGGL TVYSLGEIIT DRPGFHDESA IYPVGYCSTR IYASMKCPDQ KCLYTCQIKD
     GGVQPQFEIV PEDDPQNAIV SSSADACHAE LLRTISTTMG KLMPNLLPAG ADFFGFSHPA
     IHNLIQSCPG ARKCINYQWV KFDVCKPGDG QLPEGLPEND AAMSFEAFQR QIFDEDQNDP
     LLPGSLDLPE LQPAAFVSSY QPMYLTHEPL VDTHLQHLKS PSQGSPIQSS D
//
